Hyperthermia in human ischemic and hemorrhagic stroke: Similar outcome, different mechanisms

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Campos, Francisco ^a   Sobrino, Tomás ^a   Vieites Prado, Alba ^a   Pérez Mato, María ^a   Rodríguez Yáñez, Manuel ^a   Blanco, Miguel ^a   Castillo, José ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRONE; GELATINASE B; GLUTAMIC ACID; PARACETAMOL;

AGED; ARTICLE; BLOOD LEVEL; BODY TEMPERATURE; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CASE CONTROL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ATRIUM FIBRILLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPERTHERMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RANKIN SCALE;

AGED; AGED, 80 AND OVER; BODY TEMPERATURE; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; FEMALE; FEVER; GLUTAMIC ACID; HUMANS; LOGISTIC MODELS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84892590796     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078429     Document Type: Article

References (24)

1. Tomsick TA, Khatri P, Jovin T, Demaerschalk B, Malisch T, et al. (2010) Equipoise among recanalization strategies. Neurology 74:1069-1076.
2. Katsuki H (2010) Exploring neuroprotective drug therapies for intracerebral hemorrhage. J Pharmacol Sci 114:366-378.
3. Belur PK, Chang JJ, He S, Emanuel BA, Mack WJ (2013) Emerging experimental therapies for intracerebral hemorrhage: targeting mechanisms of secondary brain injury. Neurosurg Focus 34:E9.
4. Castillo J, Martinez F, Leira R, Prieto JMM, Lema M, et al. (1994) Mortality and Morbidity of Acute Cerebral Infarction Related to Temperature and Basal Analytic Parameters. Cerebrovasc Dis 4: 66-71.
5. den Hertog HM, van der Worp HB, van Gemert HM, Algra A, Kappelle LJ, et al. (2011) An early rise in body temperature is related to unfavorable outcome after stroke: data from the PAIS study. J Neurol 258: 302-307.
6. Balami JS, Buchan AM (2012) Complications of intracerebral haemorrhage. Lancet Neurol 11:101-118.
7. Blanco M, Campos F, Rodríguez-Yáñez M, Arias S, Fernández-Ferro J, et al. (2012) Neuroprotection or increased brain damage mediated by temperature in stroke is time dependent. PLoS One 7: e30700.
8. Campos F, Blanco M, Barral D, Agulla J, Ramos-Cabrer P, et al. (2012) Influence of temperature on ischemic brain: basic and clinical principles. Neurochem Int 60: 495-505.
9. Rincon F, Lyden P, Mayer SA (2013) Relationship between temperature, hematoma growth, and functional outcome after intracerebral hemorrhage. Neurocrit Care 18: 45-53.
10. Campos F, Pérez-Mato M, Agulla J, Blanco M, Barral D, et al. (2012) Glutamate excitoxicity is the key molecular mechanism which is influenced by body temperature during the acute phase of brain stroke. PLoS One 7: e44191.
11. Castillo J, Dávalos A, Noya M (1997) Progression of ischaemic stroke and excitotoxic aminoacids. Lancet 349:79-83.
12. Qureshi AI, Ali Z, Suri MF, Shuaib A, Baker G, et al. (2003) Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study. Crit Care Med 31:1482-1489.
13. Lee ST, Chu K, Jung KH, Kim J, Kim EH, et al. (2006) Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement. J Cereb Blood Flow Metab 26:536-544.
14. Reith J, Jørgensen HS, Pedersen PM, Nakayama H, Raaschou HO, et al. (1996) Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 347: 422-425.
15. Leira R, Rodríguez-Yáñez M, Castellanos M, Blanco M, Nombela F, et al. (2006) Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke. J Intern Med 260: 343-349.
16. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, et al. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41.
17. Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES, et al. (2009) ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72: 2104-2110.
18. Rodríguez-Yáñez M, Sobrino T, Arias S, Vázquez-Herrero F, Brea D, et al. (2011) Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke. Stroke 42: 2813-2818.
19. Campos F, Sobrino T, Ramos-Cabrer P, Castillo J (2012) Oxaloacetate: a novel neuroprotective for acute ischemic stroke. Int J Biochem Cell Biol. 44:262-265.
20. Balami JS, Buchan AM (2012) Complications of intracerebral haemorrhage. Lancet Neurol 11:101-118.
21. Abilleira S, Montaner J, Molina CA, Monasterio J, Castillo J, et al. (2003) Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. J Neurosurg 99: 65-70.
22. Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, et al. (2005) Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke 36: 86-91.
23. Li N, Liu YF, Ma L, Worthmann H, Wang YL, et al. (2013) Association of molecular markers with perihematomal edema and clinical outcome in intracerebral hemorrhage. Stroke 44: 658-663.
24. Belur PK, Chang JJ, He S, Emanuel BA, Mack WJ (2013) Emerging experimental therapies for intracerebral hemorrhage: targeting mechanisms of secondary brain injury. Neurosurg Focus 34:E9.